{"entity":{"type":"insider","cik":"0001727640","url":"/insider/0001727640","json_url":"/insider/0001727640.json","name":"Sullivan Lynne Marie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2021-07-30","last":"2025-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Sullivan Lynne Marie","source":"filing","n_filings":6,"first_seen":"2021-07-30","last_seen":"2025-04-03"}],"transactions":[{"id":4340949,"accession":"0000950170-25-050410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-050410","line_url":"/filing/0000950170-25-050410#line-1","is_derivative":false,"issuer_cik":"0001463361","issuer_name":"Unity Biotechnology, Inc.","issuer_ticker":"UBX","issuer_name_source":null,"issuer_url":"/issuer/0001463361","owner_cik":"0001727640","owner_name":"Sullivan Lynne Marie","owner_display_name":"Sullivan Lynne Marie","owner_url":"/insider/0001727640","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21867.0,"shares_display":"21,867","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":22523.01,"total_display":"22,523.01","total_whole":"22,523","shares_owned_after":98905.0,"shares_owned_after_display":"98,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-03","scope":"insider"},{"id":4494511,"accession":"0000950170-25-014570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-014570","line_url":"/filing/0000950170-25-014570#line-1","is_derivative":false,"issuer_cik":"0001463361","issuer_name":"Unity Biotechnology, Inc.","issuer_ticker":"UBX","issuer_name_source":null,"issuer_url":"/issuer/0001463361","owner_cik":"0001727640","owner_name":"Sullivan Lynne Marie","owner_display_name":"Sullivan Lynne Marie","owner_url":"/insider/0001727640","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153.0,"shares_display":"153","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":341.19,"total_display":"341.19","total_whole":"341","shares_owned_after":55772.0,"shares_owned_after_display":"55,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-05","scope":"insider"},{"id":3022425,"accession":"0000950170-24-122295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-122295","line_url":"/filing/0000950170-24-122295#line-1","is_derivative":false,"issuer_cik":"0001463361","issuer_name":"Unity Biotechnology, Inc.","issuer_ticker":"UBX","issuer_name_source":null,"issuer_url":"/issuer/0001463361","owner_cik":"0001727640","owner_name":"Sullivan Lynne Marie","owner_display_name":"Sullivan Lynne Marie","owner_url":"/insider/0001727640","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":175.44,"total_display":"175.44","total_whole":"175","shares_owned_after":55925.0,"shares_owned_after_display":"55,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-06","scope":"insider"},{"id":3216218,"accession":"0000950170-24-091964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-091964","line_url":"/filing/0000950170-24-091964#line-1","is_derivative":false,"issuer_cik":"0001463361","issuer_name":"Unity Biotechnology, Inc.","issuer_ticker":"UBX","issuer_name_source":null,"issuer_url":"/issuer/0001463361","owner_cik":"0001727640","owner_name":"Sullivan Lynne Marie","owner_display_name":"Sullivan Lynne Marie","owner_url":"/insider/0001727640","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139.0,"shares_display":"139","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":212.67,"total_display":"212.67","total_whole":"213","shares_owned_after":56061.0,"shares_owned_after_display":"56,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-06","scope":"insider"},{"id":2985024,"accession":"0000950170-24-077848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-077848","line_url":"/filing/0000950170-24-077848#line-1","is_derivative":false,"issuer_cik":"0001463361","issuer_name":"Unity Biotechnology, Inc.","issuer_ticker":"UBX","issuer_name_source":null,"issuer_url":"/issuer/0001463361","owner_cik":"0001727640","owner_name":"Sullivan Lynne Marie","owner_display_name":"Sullivan Lynne Marie","owner_url":"/insider/0001727640","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":324.0,"shares_display":"324","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":453.6,"total_display":"453.60","total_whole":"454","shares_owned_after":32685.0,"shares_owned_after_display":"32,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-26","scope":"insider"},{"id":5119379,"accession":"0001213900-21-039439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-039439","line_url":"/filing/0001213900-21-039439#line-1","is_derivative":false,"issuer_cik":"0001727640","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001727640","owner_cik":"0001727640","owner_name":"Sullivan Lynne Marie","owner_display_name":"Sullivan Lynne Marie","owner_url":"/insider/0001727640","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001463361","name":"Unity Biotechnology, Inc.","url":"/issuer/0001463361","role":"Officer (CFO & Head of Corp. Dev)","n_filings":5,"first_seen":"2024-06-26","last_seen":"2025-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001739174","name":"BiomX Inc.","url":"/issuer/0001739174","role":"Director","n_filings":1,"first_seen":"2021-07-30","last_seen":"2021-07-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727640","retrieved_at":"2026-08-22T10:03:44+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}